Applications published 9 November 2006
Compsns comprising vitamins and/or derivatives thereof stabilised with Olea europea extract and/or ionene polymers
Med Care 1718273*
Controlled and sustained delivery of nucleic acid-based therapeutic agents
Control Delivery Systems 1718275*
Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir
Alza 1718275*
Inhalant formulation containing sulphoalkylether cyclodextrin prepared from a unit dose suspension
Cydex 1718276*
Particles for inhalation rapid release properties
Advanced Inhalation Research 1718277*
Microcapsule with controllable or delayed release for immobilising chemical and/or biological material in addition to method for the production thereof
Cavis Microcaps 1718278*
Methods and compsns for treating cancer
Mars Inc 1718280*
Multilayer tablet
Boehringer Ingelheim International 1718281*
Methods and compsns for imaging
Mount Sinai School of Medicine 1718282*
Topical co-enzyme Q10 formulations and methods of use
University of Miami 1718283*
Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
Decode Genetics 1718284*
Use of a compound modulating at least one receiver selected in a group comprising an interleukin 8 type B receptor and PACAP-1 receptor for preparing a pharmaceutical compsn for rosacea treatment
Galderma Research & Development 1718285*
Nitrosated and/or nitrosylated compounds, compsns and methods of use
Nitromed 1718286*
Method of treatment or prevention of osteoporosis in individuals with high bone turnover
Hormos Medical 1718287*
Solid formulations of ospemifene
Hormos Medical 1718288*
Therapeutic methods employing nitric oxide precursors
Vanderbilt University 1718289*
Compsn, comprising L-serine, L-isoleucine, folic acid and trace elements, for treating psoriasis
Helsingfors Institution foer Bioimmuniterapi 1718290*
Use of cholinesterase inhibitors for treating vascular depression
Novartis 1718291*
Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation disorders
Aventis Pharmaceuticals; Sanofi-Aventis Deutschland 1718292*
Oxydecahydronaphthalene modulators of HM74
Aventis Pharmaceuticals 1718293*
Methods for treatment of complications of diabetes
Axonyx 1718294*
Use of metronidazole for preparing a pharmaceutical compsn for treating a cutaneous inflammation
Galderma Research & Development 1718295*
Use of a metronidazole for preparing a pharmaceutical compsn for treating pathologies related to B-type receptor of interleukin 8 and/or to a PACAP type 1 receptor
Galderma Research & Development 1718296*